Mobile Menu

News

Years

Categories

Media Inquiries

Sarah Corley

marketing@echo.global

405-753-4232

October 21, 2022

Zeno Technologies Unveils a New Platform to Help Energy Companies Thrive in the Production Era

Zeno Technologies today unveiled a new cloud-based platform to help energy companies, investors and partners adapt and thrive in the face of new market realities in the Production Era. The energy industry is fundamentally different than it was just a few short years ago, and today’s energy-focused organizations need a set of modern tools to unlock data to inform smarter, faster business decisions. Zeno’s new Energy Operating System provides the clarity to understand and improve business performance, and the insight to decisively assess and pursue new investment opportunities.

Read More

October 9, 2022

Oklahoman: Gen Xers rise up as next wave of civic leaders guiding Oklahoma City's future aspirations

Oklahoma City, long guided by waves of corporate leaders, is seeing a new, younger generation lining up behind aging baby boomers and reshaping their community economically, culturally and philanthropically. Chad Richison, 51, Christian Kanady, 43, and Bob Funk Jr., 47, are among a growing number of Gen Xers (born between 1965 and 1980) who are taking Oklahoma City in a new direction where oil and gas is giving way to a new, more diverse economy.

Read More

October 4, 2022

Wheeler Bio Announces Series A Financing Round Led by Echo, Charles River Laboratories

OKLAHOMA CITY – Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small batch clinical production of biologics and GMP-grade reagents using their open-source platform, Portable CMC™, today announced the first closing of their Series A financing round. The round was co-led by Charles River Laboratories and Echo Investment Capital with participation from ATUM, Floating Point Advisors, Plains Venture Partners (a subsidiary of i2E), and Pine Ridge Ventures.

Read More

September 8, 2022

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

Deka Biosciences ("Deka"), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.

Read More

September 2, 2022

U.S. Economic Development Administration Awards $35 million Grant to the Oklahoma Biotech Innovation Cluster

Today, President Biden will announce the Oklahoma Biotech Innovation Cluster as one of 21 winners of the $1 billion Build Back Better Regional Challenge, the most impactful regional economic development competition in decades. Funded by President Biden’s American Rescue Plan and administered by the U.S. Department of Commerce’s Economic Development Administration (EDA), the Regional Challenge is awarding approximately $35 million in grants to the Oklahoma Biotech Innovation Cluster, led by the Oklahoma City Economic Development Foundation, to expand the biotechnology industry in the Oklahoma City region.

Read More

Let’s build something great together.